IL2 and neoplasm: Intriguingly, although the BiTE could activate T cells, it did not lead to T‐cell proliferation without the addition of exogenous IL‐2, whereas the BiTE used in the current study led to extensive proliferation both of PBMC in vitro and of tumour‐associated lymphocytes using the clinical biopsy samples ex vivo.